INTENSITY THERAPEUTICS, INC. (INTS) Form 10-Q Quarterly Reports
INTENSITY THERAPEUTICS, INC. (INTS) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INTS
CIK: 1567264
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
EisnerAmper LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerSharon Keenan
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001567264-26-000061 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001567264-26-000059 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001231945-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001934188-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001278042-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001875180-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001895944-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001524547-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-16 | FORM 4 | 0001238705-26-000007 | View SEC Doc Filr Page |
| S-8 | 2026-07-08 | — | S-8 | 0001567264-26-000054 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001895944-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001524547-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-16 | 8-K | 0001567264-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001567264-26-000047 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001567264-26-000046 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001567264-26-000037 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001567264-26-000036 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-04-30 | DEF 14A | 0001567264-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-03-30 | 2026-03-26 | FORM 4 | 0001238705-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-27 | 8-K | 0001567264-26-000025 | View SEC Doc Filr Page |
| 10-K | 2026-03-27 | 2025-12-31 | 10-K | 0001567264-26-000024 | View SEC Doc Filr Page |
| 8-K | 2026-03-23 | 2026-03-23 | 8-K | 0001567264-26-000021 | View SEC Doc Filr Page |
| 424B5 | 2026-03-23 | — | 424B5 | 0001567264-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-03-06 | 2026-03-05 | 8-K | 0001567264-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-03-05 | 8-K | 0001567264-26-000011 | View SEC Doc Filr Page |